System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Claire Bonneau is an expert in Oncology at Institut Curie (France). Claire Bonneau has authored 117 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 375 (community average: 125). How the SLR is computed.

LeadR Profile

Claire Bonneau Institut Curie France
375 ScienceLeadR Reputation 375

Unlock

Register Login
Network Map

Oncology

Subspecialties: Gynecology - Surgery - Medical Imaging

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2010 - 2026
Source: PubMed

Versailles Saint-Quentin-en-Yvelines University

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 117

Citations

Citations: 4 284 1st author: 18 Last author: 16 Unique author: 0

Main journals

Bull Cancer 7
Anticancer Res 4
Ann Oncol 3
Cancer Res 3
Clin Breast Cancer 3

Best Journals

Ann Oncol 2
Cancer Discov 2
J Clin Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
H3K4me1-Mediated Epigenomic Priming of Chemoresistant Tumor States in Ovarian Cancer.
PMID 42895184 — cells, epigenomics, ovary, neoplasms, biopsy, ovarian neoplasms, histones, therapeutics		Cancer Discov Top journal20260
[Characteristics and performance of the new assessment method during the national digital interfaculty practice exams for the second cycle of medical education].
PMID 42624686 — education, medical, internal medicine, education, universities		Rev Med Interne20260
Breast skin ulceration in de novo metastatic breast cancer: incidence, predictors, and patterns of occurrence.
PMID 42584500 — skin, breast neoplasms, incidence, neoplasms, breast		Breast Cancer Res Treat20260
Imaging patterns and diagnostic challenges in metastatic invasive lobular carcinoma.
PMID 42571762 — radiology, fluorodeoxyglucose f18, nuclear medicine, carcinoma, lobular		Eur J Radiol20261
Ultrasensitive circulating tumor DNA detection improves prognostication in triple-negative breast cancer postneoadjuvant therapy.
PMID 42531804 — triple negative breast neoplasms, circulating tumor dna, breast neoplasms, neoplasms, biomarkers, neoplasm metastasis, breast, neoadjuvant therapy, therapeutics, dna, plasma		ESMO Open20261

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 2
Phase 1/Phase 2 1

By status:

Active not recruiting 1
Completed 1
Not yet recruiting 1

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 0
multicentricup10 2

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53 Mutated Endometrial Cancer A Non Inferiority Randomized Trial
NCT06900582 — genes, lymph nodes, lymph node excision, ureter, neoplasms, sentinel lymph node, biopsy, arteries, genes, p53, lymph, tissues, ligaments, sentinel lymph node biopsy, indocyanine green, anatomy, iliac artery, mutation, dissection, endometrial neoplasms, cervix uteri		N/ANot yet recruiting2026

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS